Gastro-intestinal patch system for the delivery of erythropoietin

Journal of Controlled Release

Volumn 111, Issue 1-2, 2006, Pages 19-26

  Venkatesan, N ^a   Uchino, K ^a   Amagase, K ^a   Ito, Y ^a   Shibata, N ^a   Takada, K ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Erythropoietin; Gastro intestinal patches; Gelucire 44 14; HCO 60; Labrasol

Indexed keywords

ABSORPTION; DERIVATIVES; SURFACE ACTIVE AGENTS; VEGETABLE OILS;

ERYTHROPOIETIN; GASTRO-INTESTINAL PATCHES; GELUCIRE 44/14; HCO-60; LABRASOL;

GASTROENTEROLOGY;

ERYTHROPOIETIN; GELUCIRE; LABRASOL; RECOMBINANT ERYTHROPOIETIN; RICINOMACROGOL; SURFACTANT;

ADSORPTION KINETICS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT; HISTOLOGY; JEJUNUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE; TOXICITY TESTING;

ADMINISTRATION, ORAL; ALGORITHMS; ANIMALS; AREA UNDER CURVE; CASTOR OIL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ERYTHROPOIETIN; GASTROINTESTINAL TRACT; INTESTINAL ABSORPTION; JEJUNUM; MALE; METABOLIC CLEARANCE RATE; ORGANIC CHEMICALS; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR;

EID: 33344479101     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.11.009     Document Type: Article

References (40)

1. E. Goldwasser, and C.K.H. Kung Progress in the purification of erythropoietin Ann. N. Y. Acad. Sci. 149 1968 49 53
2. C.G. Winerals, D.O. Olivar, M.J. Pippard, C. Reid, M.R. Downing, and P.R. Cotes Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis Lancet 1986 1175 1177 (ii)
3. J.W. Eschbach, J.C. Egrie, M.R. Downing, J.K. Browne, and J.W. Adamson Correction of the anemia of end-stage renal disease with recombinant human erythropoietin N. Engl. J. Med. 316 1987 73 78
4. A. Urabe, T. Takaku, H. Mizoguchi, K. Kubo, K. Ota, N. Shimizu, K. Tanaka, N. Miura, H. Nihei, S. Koshikawa, T. Akizawa, N. Akiyama, O. Otsubo, Y. Kawaguchi, and T. Maeda Effect of recombinant human erythropoietin on the anemia of chronic renal failure Int. J. Cell Cloning 6 1988 179 191
5. J. Spivak Recombinant human erythropoietin and the anaemia of cancer Blood 84 4 1994 997 1004
6. A. Markham, and H. Bryson Epoetin alfa, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in non-renal applications Drugs 49 2 1995 232 254
7. J.M. Davis, T. Aralkawas, T.W. Strickland, and D.A. Yphantis Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells Biochemistry 26 1987 2633 2638
8. Y. Maitani, M. Hazama, Y. Tojo, N. Simoda, and T. Nagai Oral administration of recombinant human erythropoietin in liposomes in rats: influence of lipid composition and size of liposomes on bioavailability J. Pharm. Sci. 85 4 1996 440 445
9. Y. Maitani, H. Moriya, N. Shimoda, K. Takayama, and T. Nagai Distribution characteristics of entrapped recombinant human erythropoietin in liposomes and its intestinal absorption in rats Int. J. Pharm. 185 1999 13 22
10. A. Mizuno, M. Ueda, and G. Kawanishi Effects of salicylate and other enhancers on rectal absorption of erythropoietin in rats J. Pharm. Pharmacol. 44 1992 570 573
11. N. Shimoda, Y. Maitani, Y. Machida, and T. Nagai Effects of dose, pH and osmolarity on intranasal absorption of recombinant human erythropoietin in rats Biol. Pharm. Bull. 18 5 1995 734 739
12. S. Eaimtrakarn, Y. Itoh, J. Kishimoto, Y. Yoshikawa, N. Shibata, and K. Takada Retention and transit of intestinal mucoadhesive films in rat small intestine Int. J. Pharm. 224 2001 61 67
13. S. Eaimtrakarn, Y. Itoh, J. Kishimoto, Y. Yoshikawa, N. Shibata, M. Murakami, and K. Takada Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein Biomaterials 23 2002 145 152
14. S. Eaimtrakarn, Y.V. Rama Prasad, S.P. Puthli, Y. Yoshikawa, N. Shibata, and K. Takada Possibility of a patch system as a new oral delivery system Int. J. Pharm. 250 2003 111 117
15. Z. Shen, and S. Mitragotri Intestinal patches for oral drug delivery Pharm. Res. 19 2002 391 395
16. K. Whitehead, Z. Shen, and S. Mitragotri Oral delivery of macromolecules using intestinal patches: application for insulin delivery J. Control. Release 98 2004 37 45
17. A. Mori, A. Matsuura, Y.V. Rama Prasad, and K. Takada Studies on the intestinal absorption of low molecular weight heparin using saturated fatty acids and their derivatives as an absorption enhancer in rats Biol. Pharm. Bull. 27 2004 418 421
18. M. Tomita, M. Hyayashi, T. Horie, T. Ishizawa, and S. Awazu Enhancement of colonic drug absorption by the transcellular permeation route Pharm. Res. 5 1988 786 789
19. E.K. Anderberg, T. Lindmark, and P. Artursson Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route Pharm. Res. 10 1993 857 864
20. T. Lindmark, T. Mikkila, and P. Artursson Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers J. Pharmcol. Exp. Ther. 275 1995 958 964
21. T. Lindmark, Y. Kimura, and P. Artursson Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells J. Pharmacol. Exp. Ther. 284 1998 362 369
22. P.J. Sinko, Y.H. Lee, V. Makhey, G.D. Leesman, J.P. Sutyak, H. Yu, B. Perry, C.L. Smith, P. Hu, E.J. Wagner, L.M. Falzone, L.T. McWhorter, J.P. Gilligan, and W. Stern Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT) Pharm. Res. 16 1999 527 533
23. S. Eaimtrakarn, Y.V. Rama Prasad, T. Ohno, T. Konishi, Y. Yoshikawa, N. Shibata, and K. Takada Absorption enhancing effect of Labrasol on the intestinal absorption of insulin in rats J. Drug Target. 10 2002 255 260
24. Y.V. Rama Prasad, S.P. Puthli, S. Eaimtrakarn, M. Ishida, Y. Yoshikawa, N. Shibata, and K. Takada Enhanced intestinal absorption of vancomycin with Labrasol and d-α-tocopheryl PEF 1000 succinate in rats Int. J. Pharm. 250 2003 181 190
25. Z. Hu, R. Tawa, T. Konishi, N. Shibata, and K. Takada A novel emulsifier, Labrasol, enhances gastrointestinal absorption of gentamicin Life Sci. 69 2001 2899 2910
26. Z. Hu, Y.V. Rama Prasad, R. Tawa, T. Konishi, M. Ishida, N. Shibata, and K. Takada Diethyl ether fraction of Labrasol having a stronger absorption enhancing effect on gentamicin than Labrasol itself Int. J. Pharm. 234 2002 223 235
27. D.Q.M. Craig The use of glycerides as controlled release matrices D.R. Karsa R.A. Stephenson Excipients and Delivery Systems for Pharmaceutical Formulations 1995 Royal Society of Chemistry London 148 173
28. P.C. Sheen, S.I. Kin, J.J. Petillo, and A.T.M. Serajuddin Bioavailability of a poorly water-soluble drug from tablet and solid dispersions in humans J. Pharm. Sci. 80 1991 712 714
29. F. Pozzi, A. Longo, C. Lazzarini, and A. Carenzi Formulations of ubidecarenon with improved bioavailability Eur. J. Pharm. Biopharm. 37 1991 243 246
30. B.J. Aungst, N.H. Nguyen, N.J. Rogers, S.M. Rowe, M.A. Hussain, S.J. White, and L. Shum Amphiphilic vehicles improve the oral bioavailability of a poorly soluble HIV protease inhibitor at high doses Int. J. Pharm. 156 1997 79 88
31. S.A. Barker, S.P. Yap, K.H. Yuen, C.P. McCoy, J.R. Murphy, and D.Q.M. Craig An investigation into the structure and bioavailability of α-tocopherol dispersions in Gelucire 44/14 J. Control. Release 91 2003 477 488
32. H. Yoshikawa, K. Takada, and S. Muranishi Effect of storage on the ability of lipid-surfactant mixed micelles to promote enteral absorption of bleomycin in rats Chem. Pharm. Bull. 34 1986 4382 4384
33. M.J. Cho, J.F. Scieszka, and P.S. Burton Citric acid as an adjuvant for transpeithelial transport Int. J. Pharm. 52 1989 79 81
34. K. Takada, and Y. Ushirogawa Effect of pH, dietary proteins and trypsin inhibitors on the hydrolytic rate of human granulocyte colony-stimulating factor (rhG-CSF) by rat digestive enzymes J. Pharmacobio-Dyn. 14 1991 363 370
35. Y. Ushirogawa, Y. Nakahigashi, A. Kiriyama, and K. Takada Effect of organic acids, trypsin inhibitors and dietary protein on the pharmacological activity of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats Int. J. Pharm. 81 1992 133 141
36. T. Takaya, K. Niwa, and K. Takada Pharmacological effect of recombinant human colony-stimulating factor (rhG-CSF) after administration into rat large intestine Int. J. Pharm. 110 1994 47 53
37. M. Hayashi, T. Sakai, and T. Hasegawa Physiological mechanism for enhancement of paracellular drug transport J. Control. Release 62 1999 141 148
38. T.T. Kararli Comparison of the gastrointestinal anatomy, physiology and biochemistry of humans and commonly used laboratory animals Biopharm. Drug Dispos. 16 1995 351 380
39. M. Sekine, E. Maeda, K. Sasahara, R. Okada, K. Kimuara, M. Fukami, and S. Awazu Improvement of bioavailability of poorly absorbed drugs III. Oral acute toxicity and local irritation of medium chain glyceride J. Pharmacobio-Dyn. 8 1985 633 644
40. S.W. Cho, J.S. Lee, and S.H. Choi Enhanced oral bioavailability of poorly absorbed drugs. I. Screening of absorption carrier for the ceftriaxone complex J. Pharm. Sci. 92 2004 612 620